C005
LEVEL OF LYMPH NODE METASTASIS ADDS PROGNOSTIC VALUE TO AMERICAN JOINT COMMITTEE ON CANCER NODAL STAGING FOR SQUAMOUS CELL CARCINOMA OF THE FLOOR OF MOUTH
Oral Cancer
Alexander N Goel, BA, Suraj A Dhanjani, Albert Y Han, MD, Karam W Badran, MD, Maie A St. John, MD, PhD
Department of Head and Neck Surgery, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, California, USA
C006
INHIBITION OF TRKB RECEPTOR ON THE MIGRATION OF HUMAN SCHWANN CELL AND ORAL TONGUE SQUAMOUS CELL CARCINOMA IN VITRO
Liliana Ein, MD1, Olena Bracho, BS1, Paula Monje, PhD1, Cristina Fernandez, PhD2, Giovana Thomas, MD1, Donald Weed, MD1, Zoukaa Sargi, MD, MPH1, Christine Dinh, MD1
1University of Miami Miller School of Medicine, 2University of Central Florida Burnett School of Biomedical Sciences
C007
NODAL YIELD AND LOG ODDS RATIO ARE ASSOCIATED WITH SURVIVAL OUTCOMES IN EARLY STAGE CLINICALLY NODE-NEGATIVE ORAL CAVITY SQUAMOUS CELL CARCINOMA
Anuraag S Parikh, MD, Ayaz Khawaja, MD, Besher Assi, Joseph Zenga, MD, Mark A Varvares, MD
Massachusetts Eye and Ear Infirmary
C008
FACTORS PREDICTIVE OF ELECTIVE NECK DISSECTION (END) IN PATIENTS WITH CN0 HARD PALATE AND UPPER GINGIVAL SCC AND THE IMPACT OF END ON SURVIVAL
A Obayemi, MD1, M Cohen, MD1, R Rahmati, MD2, J Migliacci1, J C Cracchiolo1, B Roman1
1Memorial Sloan Kettering Cancer Center, 2Columbia University Medical Center
C009
VALIDATION OF AN UPDATED GRAPHIC EDUCATION TOOL IN AN ORAL RINSE POINT-OF-CARE ASSAY TO AID IN THE DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)
Michael J Donovan, Dr1, Greg Ginn2, Elizabeth Franzmann, MD3
1Icahn School of Medicine at Mt. Sinai, 2Vigilant Biosciences, 3University of Miami
C010
A POPULATION-BASED ANALYSIS OF A RARE NASOPHARYNGEAL MALIGNANCY: 1677 CASES OF LYMPHOEPITHELIAL CARCINOMA
Neel R Sangal, BA, Sarangdev Vaidya, BA, Monica C Azmy, BS, Jean Anderson Eloy, MD, FACS, Soly Baredes, MD, FACS, Richard C Park, MD, FACS
New Jersey Medical School
C011
INCREASED LYMPH NODE YIELD POSITIVELY IMPACTS OVERALL SURVIVAL IN NON-HPV BUT NEGATIVELY IMPACTS HPV-RELATED OROPHARYNGEAL CANCER
Chelsea S Hamill, MD1, Kevin J Sykes, PhD, MPH2, Sue M Lai, MS, MBA, PhD2, Thomas O'Toole, MD3
1University Hospitals/Cleveland Medical Center, 2University of Kansas Medical Center, 3Spectrum Health/Michigan State University
C012
PATIENT REPORTED OUTCOMES AND OBJECTIVE ANALYSIS OF FUNCTION FOLLOWING GLOSSECTOMY WITH RECONSTRUCTION
Suhael R Momin, MD1, Nirali Shah, BS2, Diana Cook, MA, CCCSLP1, Kathryn Genoa, MS, CCCSLP1, Tamer A Ghanem, MD, PhD1, Steven S Chang, MD1, Amy M Williams, PhD1
1Henry Ford Health System, 2Wayne State University School of Medicine
C013
THE HUMAN PAPILLOMA VIRUS: A VARIANCE IN ITS PROGNOSTIC VALUE AT DIFFERENT HEAD AND NECK SUB-SITES
Hong Li, BA1, Sina J Torabi, BA1, Saral Mehra, MD, MBA, FACS2, Heather A Osborn, MD, FRCS2, Wendell G Yarbrough, MD, MMHC, FACS2, Benjamin L Judson, MD, MGA2
1Yale School of Medicine, 2Yale New Haven Hospital
C014
OUTCOMES OF TRANSORAL SURGERY IN THE MANAGEMENT OF HPV-NEGATIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Rahul K Sharma, BS, Michael Veshkini, BS, Dorina Kallogjeri, MD, MPH, Ryan S Jackson, MD
Department of Otolaryngology Head and Neck Surgery, Washington University, St. Louis, Missouri, U.S.A.
AHNS Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)
April 18–19, 2018 Gayloard National Resortand Convention CenterNational Harbor, MD
Tips on Using this Site
Locate an abstract by entering any author's surname into the search box. You may also search by keyword or program ID number.
Broaden your search by typing only a few letters of a keyword; however, do not append the wildcard “*” to a search string.
Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.
Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.
Browser Compatibility
For the best user experience on this or any website, it is important that your browser remain up-to-date with current standards.
We support Microsoft Internet Explorer 10+, Microsoft Edge, Mozilla Firefox, Google Chrome and any other modern web browser compatible with HTML5 and CSS3.